首页> 外文期刊>Journal of Biosciences >Construction of an infectious cDNA clone of foot-and-mouth disease virus type O_1BFS 1860 and its use in the preparation of candidate vaccine
【24h】

Construction of an infectious cDNA clone of foot-and-mouth disease virus type O_1BFS 1860 and its use in the preparation of candidate vaccine

机译:O_1BFS 1860型口蹄疫病毒感染性cDNA克隆的构建及其在制备候选疫苗中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Foot-and-mouth disease virus (FMDV) serotype O is the most predominant among the endemic serotypes in India. A stable, full-length cDNA clone of FMDV type O_1BFS 1860 preceded by a bacteriophage T7 polymerase promoter was assembled in a plasmid vector pGEM~R-7Zf(-). An ~8.2 kb PCR product was amplified from the cDNA clone and a full-length RNA was generated from it by in vitro transcription. Transfection of BHK-21 cells with the in vitro transcripts resulted in the production of infectious recombinant FMDV particles as evidenced by cytopathic effects (CPE). Further, characterization of the recombinant virus by immunofluorescence, microneutralization test (MNT), antigen ELISA, RT-PCR, plaque assay and electron microscopy revealed similarity to the parental strain. The immunogenicity of an oil-adjuvant vaccine prepared using the inactivated recombinant virus was tested in guinea pigs and cattle. Neutralizing antibodies were produced in both vaccinated guinea pigs and cattle. Vaccinated animals were protected on challenge. The results demonstrated that the recombinant virus was as stable and effective as the parental strain for the preparation of inactivated vaccine, suggesting the potential application of this strategy to make genetically engineered FMDV vaccines.
机译:O型口蹄疫病毒(FMDV)血清型是印度地方性血清型中最主要的。在质粒载体pGEM_R-7Zf(-)中装配了FMDV O_1BFS 1860型稳定,全长的cDNA克隆,之后是噬菌体T7聚合酶启动子。从cDNA克隆中扩增出一个约8.2 kb的PCR产物,并通过体外转录从中产生了全长RNA。 BHK-21细胞体外转录物的转染导致感染性重组FMDV颗粒的产生,如细胞病变效应(CPE)所证明。此外,通过免疫荧光,微中和试验(MNT),抗原ELISA,RT-PCR,噬菌斑测定和电子显微镜对重组病毒进行表征,发现与亲本菌株相似。使用灭活的重组病毒制备的油佐剂疫苗的免疫原性在豚鼠和牛中进行了测试。在疫苗接种的豚鼠和牛中均产生中和抗体。接种疫苗的动物在攻击时受到保护。结果表明,该重组病毒与用于制备灭活疫苗的亲本菌株一样稳定和有效,表明该策略在制备基因工程FMDV疫苗中的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号